Skip to main content
SpringerLink
Log in

Diagnostic and Prognostic Biomarkers in Emergency Department Heart Failure

  • Chapter
  • First Online:
Short Stay Management of Acute Heart Failure

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 1054 Accesses

Abstract

Heart failure is a growing public health issue worldwide. Significant challenges still remain in the diagnosis and risk stratification of acute heart failure in the emergency department. Biomarkers, with their objectivity, reproducibility, and widespread availability, have an indispensable role in improving heart failure diagnostic accuracy and risk stratification. Natriuretic peptides are perhaps the most well-known and validated biomarkers for the diagnosis of acute heart failure. They have become a routine part of the diagnostic workup of acute heart failure in many clinical settings. Natriuretic peptides along with traditional biomarkers such as troponin, creatinine, blood urea nitrogen, and serum sodium can help to identify high-risk patients who may need closer monitoring and more intensive therapy. In addition, many novel biomarkers have emerged from basic science laboratories worldwide to provide insight into different pathophysiological processes involved in heart failure. These exciting new biomarkers include mid-region proadrenomedullin (MR-proADM), C-terminal pre-pro-vasopressin (copeptin), ST2, high-sensitivity troponin, and neutrophil gelatinase-associated lipocalin (NGAL). With more experience, these new biomarkers can provide an ever clearer picture into the pathophysiology of heart failure, leading to more accurate diagnosis and better risk stratification of heart failure patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maisel A, Mueller C, Adams Jr K, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10(9):824–39.

    Article  PubMed  CAS  Google Scholar 

  2. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161–7.

    Article  PubMed  CAS  Google Scholar 

  3. Januzzi Jr JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948–54.

    Article  PubMed  CAS  Google Scholar 

  4. Maisel A, Mueller C, Nowak R, et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol. 2010;55(19):2062–76.

    Article  PubMed  CAS  Google Scholar 

  5. Fonarow GC, Peacock WF, Phillips CO, et al. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol. 2007;49(19): 1943–50.

    Article  PubMed  CAS  Google Scholar 

  6. Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007;115(24):3103–10.

    Article  PubMed  CAS  Google Scholar 

  7. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation. 2004;110:2168–74.

    Article  PubMed  CAS  Google Scholar 

  8. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004;350(7):655–63.

    Article  PubMed  CAS  Google Scholar 

  9. Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol. 2007;49(16):1733–9.

    Article  PubMed  CAS  Google Scholar 

  10. Lainchbury JG, Troughton RW, Strangman KM. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol. 2009;55(1):53–60.

    Article  PubMed  Google Scholar 

  11. Pfisterer M, Buser P, Rickli H. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA. 2009;301(4):383–92.

    Article  PubMed  CAS  Google Scholar 

  12. Fonarow GC, Adams Jr KF, Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572–80.

    Article  PubMed  CAS  Google Scholar 

  13. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116:466–73.

    Article  PubMed  CAS  Google Scholar 

  14. Vaz Pérez A, Otawa K, Zimmermann AV, et al. The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure. Eur J Heart Fail. 2010; 12(2):122–8.

    Article  PubMed  Google Scholar 

  15. Aronson D, Burger AJ. The relationship between transient and persistent worsening renal function and mortality in patients with acute decompensated heart failure. J Card Fail. 2010; 16(7):541–7.

    Article  PubMed  Google Scholar 

  16. Peacock 4th WF, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358(20):2117–26.

    Article  PubMed  CAS  Google Scholar 

  17. Xue Y, Clopton P, Peacock WF, et al. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail. 2011;13(1):37–42.

    Article  PubMed  CAS  Google Scholar 

  18. Klein L, O’Connor CM, Leimberger JD, et al. OPTIME-CHF Investigators. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation. 2005;111(19): 2454–60.

    Article  PubMed  CAS  Google Scholar 

  19. Kearney MT, Fox KA, Lee AJ, et al. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol. 2002;40(10):1801–8.

    Article  PubMed  Google Scholar 

  20. Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA. 2003;290(19):2581–7.

    Article  PubMed  CAS  Google Scholar 

  21. Jougasaki M, Burnett Jr JC. Adrenomedullin: potential in physiology and pathophysiology. Life Sci. 2000;66(10):855–72.

    Article  PubMed  CAS  Google Scholar 

  22. Morgenthaler NG, Struck J, Alonso C, et al. Measurement of midregional proadrenomedullin in plasma with an immunoluminometricassay. Clin Chem. 2005;51:1823–9.

    Article  PubMed  CAS  Google Scholar 

  23. Weinberg EO, Shimpo M, de Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 2002;106(23):2961–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  24. Shah RV, Januzzi Jr JL. ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr Heart Fail Rep. 2010;7(1):9–14.

    Article  PubMed  CAS  Google Scholar 

  25. Weinberg EO, Shimpo M, Hurwitz S, et al. Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation. 2003;107(5):721–6.

    Article  PubMed  Google Scholar 

  26. Bayes-Genis A, Pascual-Figal D, Januzzi JL, et al. Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol. 2010;63(10):1171–8.

    Article  Google Scholar 

  27. Januzzi Jr JL, Peacock WF, Maisel AS, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007;50(7):607–13.

    Article  PubMed  CAS  Google Scholar 

  28. Pascual-Figal DA, Ordoñez-Llanos J, Tornel PL, et al. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. J Am Coll Cardiol. 2009;54(23):2174–9.

    Article  PubMed  CAS  Google Scholar 

  29. Daniels LB, Clopton P, Iqbal N, et al. Association of ST2 levels with cardiac structure and function and mortality in outpatients. Am Heart J. 2010;160(4):721–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA San Diego Healthcare System, San Diego, CA, USA

    Yang Xue MD, Arrash Fard MD, Navaid Iqbal MD & Alan Maisel MD

Authors
  1. Yang Xue MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arrash Fard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Navaid Iqbal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alan Maisel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yang Xue MD .

Editor information

Editors and Affiliations

  1. Mail Code E-19, Cleveland Clinic Foundation Dept. Emergency Medicine, Cleveland, Ohio, USA

    W. Frank Peacock

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Xue, Y., Fard, A., Iqbal, N., Maisel, A. (2012). Diagnostic and Prognostic Biomarkers in Emergency Department Heart Failure. In: Peacock, W. (eds) Short Stay Management of Acute Heart Failure. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-627-2_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-627-2_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-626-5

  • Online ISBN: 978-1-61779-627-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation